BOLT – bolt biotherapeutics, inc. (US:NASDAQ)
Stock Stats
News
Bolt Biotherapeutics (NASDAQ:BOLT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Form 4 Bolt Biotherapeutics, For: Jan 28 Filed by: Quinn William P.
Form 4 Bolt Biotherapeutics, For: Jan 28 Filed by: Nemec Sarah
Form 4 Bolt Biotherapeutics, For: Jan 28 Filed by: Yonehiro Grant
Form 4 Bolt Biotherapeutics, For: Dec 12 Filed by: ONETTO NICOLE
Form 4 Bolt Biotherapeutics, For: Dec 12 Filed by: Dupont Jakob
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.